These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

993 related articles for article (PubMed ID: 29398533)

  • 41. Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume.
    Selim M; Fink JN; Kumar S; Caplan LR; Horkan C; Chen Y; Linfante I; Schlaug G
    Stroke; 2002 Aug; 33(8):2047-52. PubMed ID: 12154261
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preprocedure Intravenous Recombinant Tissue Plasminogen Activator and Risk of Distal Embolization with Thrombectomy in Acute Ischemic Stroke.
    Qureshi AI; Asif A; Aytac E; Liaqat J; Gurkas E; Lobanova I; Saeed O; Ahsan H; Siddiq F; Gomez CR; French BR
    J Stroke Cerebrovasc Dis; 2019 Dec; 28(12):104362. PubMed ID: 31562039
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and radiological factors associated with unfavorable outcome after intravenous thrombolysis in patients with mild ischemic stroke.
    Kim DH; Lee DS; Nah HW; Cha JK
    BMC Neurol; 2018 Mar; 18(1):30. PubMed ID: 29544461
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cerebral microbleeds on T2*-weighted images and hemorrhagic transformation after antithrombotic therapies for ischemic stroke.
    Takahashi W; Moriya Y; Mizuma A; Uesugi T; Ohnuki Y; Takizawa S
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e528-32. PubMed ID: 23830955
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High Plasma D-Dimer Indicates Unfavorable Outcome of Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis.
    Hsu PJ; Chen CH; Yeh SJ; Tsai LK; Tang SC; Jeng JS
    Cerebrovasc Dis; 2016; 42(1-2):117-21. PubMed ID: 27088493
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Accuracy of Stroke Diagnosis in Telestroke-Guided Tissue Plasminogen Activator Patients.
    Agrawal K; Raman R; Ernstrom K; Claycomb RJ; Meyer DM; Hemmen TM; Modir RF; Kachhi P; Meyer BC
    J Stroke Cerebrovasc Dis; 2016 Dec; 25(12):2942-2946. PubMed ID: 27599906
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stroke outcomes of Japanese patients with major cerebral artery occlusion in the post-alteplase, pre-MERCI era.
    Endo K; Koga M; Sakai N; Yamagami H; Furui E; Matsumoto Y; Shiokawa Y; Yoshimura S; Okada Y; Nakagawara J; Hyogo T; Hasegawa Y; Nagashima H; Fujinaka T; Hyodo A; Terada T; Toyoda K;
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):805-10. PubMed ID: 22721823
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A matched comparison of eptifibatide plus rt-PA versus rt-PA alone in acute ischemic stroke.
    Adeoye O; Knight WA; Khoury J; Schmit PA; Sucharew H; Broderick JP; Pancioli AM;
    J Stroke Cerebrovasc Dis; 2014; 23(5):e313-5. PubMed ID: 24534128
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renal Dysfunction Associated with Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis.
    Zhu J; Shen X; Han C; Mei C; Zhou Y; Wang H; Kong Y; Jiang Y; Fang Q; Cai X
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104363. PubMed ID: 31501038
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is there a decreased risk of intracerebral hemorrhage and mortality in obese patients treated with intravenous thrombolysis in acute ischemic stroke?
    Hassan AE; Chaudhry SA; Jani V; Grigoryan M; Khan AA; Adil MM; Qureshi AI
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):545-9. PubMed ID: 23453555
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours.
    Thomalla G; Sobesky J; Köhrmann M; Fiebach JB; Fiehler J; Zaro Weber O; Kruetzelmann A; Kucinski T; Rosenkranz M; Röther J; Schellinger PD
    Stroke; 2007 Feb; 38(2):313-8. PubMed ID: 17204683
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combined approach to lysis utilizing eptifibatide and recombinant tissue plasminogen activator in acute ischemic stroke-enhanced regimen stroke trial.
    Pancioli AM; Adeoye O; Schmit PA; Khoury J; Levine SR; Tomsick TA; Sucharew H; Brooks CE; Crocco TJ; Gutmann L; Hemmen TM; Kasner SE; Kleindorfer D; Knight WA; Martini S; McKinney JS; Meurer WJ; Meyer BC; Schneider A; Scott PA; Starkman S; Warach S; Broderick JP;
    Stroke; 2013 Sep; 44(9):2381-7. PubMed ID: 23887841
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Worse stroke outcome in atrial fibrillation is explained by more severe hypoperfusion, infarct growth, and hemorrhagic transformation.
    Tu HT; Campbell BC; Christensen S; Desmond PM; De Silva DA; Parsons MW; Churilov L; Lansberg MG; Mlynash M; Olivot JM; Straka M; Bammer R; Albers GW; Donnan GA; Davis SM;
    Int J Stroke; 2015 Jun; 10(4):534-40. PubMed ID: 23489996
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Higher Left Ventricle Mass Indices Predict Favorable Outcome in Stroke Patients with Thrombolysis.
    Wu F; Cao W; Ling Y; Yang L; Cheng X; Dong Q
    J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1609-13. PubMed ID: 25959501
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictors of functional outcome and hemorrhagic complications in acute ischemic stroke patients treated with intravenous thrombolysis - A retrospective analysis
.
    Zhao Q; Shan W; Liu L; Fu X; Liu P; Hu Y
    Int J Clin Pharmacol Ther; 2017 Dec; 55(12):893-900. PubMed ID: 29092734
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intravenous Tissue Plasminogen Activator for Wake-Up Stroke: A Propensity Score-Matched Analysis.
    Anaissie JE; Monlezun DJ; Siegler JE; Waring ED; Dowell LN; Samai AA; George AJ; Kimbrough T; Berthaud J; Martin-Schild S
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2603-2609. PubMed ID: 27476340
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drop of PT Quick percent value is associated with both symptomatic and asymptomatic intracranial hemorrhage in patients treated with rt-PA for acute ischemic stroke.
    Alonso A; Dempfle CE; Szabo K; Zohsel K; Hennerici MG
    Thromb Res; 2011 Jan; 127(1):65-6. PubMed ID: 20537372
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical implication of hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator.
    Ho BL; Chen CF; Lin RT; Liu CK; Chao AC
    Neurol Sci; 2016 Nov; 37(11):1799-1805. PubMed ID: 27423451
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
    Roveri L; La Gioia S; Ghidinelli C; Anzalone N; De Filippis C; Comi G
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):703-8. PubMed ID: 22133742
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator.
    Ong CT; Wong YS; Wu CS; Su YH
    Drug Des Devel Ther; 2017; 11():1559-1566. PubMed ID: 28572721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.